Actively Recruiting
TelePrEP for At-risk Youth in Colorado
Led by University of Colorado, Denver · Updated on 2024-05-08
100
Participants Needed
1
Research Sites
102 weeks
Total Duration
On this page
Sponsors
U
University of Colorado, Denver
Lead Sponsor
G
Gilead Sciences
Collaborating Sponsor
AI-Summary
What this Trial Is About
Youth represent the largest proportion of new HIV infections in Colorado, reflective of their inadequate access and uptake of pre-exposure prophylaxis(PrEP)for HIV prevention. Colorado's 2019 HIV/AIDS Prevention Program state-wide review of PrEP barriers showed PrEP eligible individuals do not access PrEP services due to lack of interest, not wanting referral to a navigator, and low estimation of HIV risk. The overall goal is to provide youth at higher risk for HIV with an effective youth informed telemedicine delivery of PrEP (TelePrEP) that addresses PrEP barriers and contributes to ending the HIV epidemic in Colorado. The primary objective will be proportion of youth retained on PrEP 12 months after initiation. The hypotheses are that a TelePrEP model for youth will be acceptable and feasible and will result in successful initiation, persistence and retention on oral PrEP.
CONDITIONS
Official Title
TelePrEP for At-risk Youth in Colorado
Who Can Participate
Eligibility Criteria
You may qualify if you...
- HIV negative
- Eligible for PrEP using emtricitabine/tenofovir alafenamide (F/TAF) based on current CDC guidance
- Assigned male at birth
- Has had male sex partners in the past 6 months and is not in a monogamous partnership with a recently tested, HIV-negative man
- Has had any sex without a condom in the past 6 months or has had a bacterial sexually transmitted infection
- Consents to TelePrEP visits
- Willing to use current insurance coverage for clinic and laboratory services or willing to obtain insurance or eligible for other coverage such as Title X funds or charity care
You will not qualify if you...
- HIV infection or concern for acute HIV infection until ruled out
- Pregnancy
- Persons at risk through receptive vaginal sex including cisgender women and transgender men (persons assigned female sex at birth)
- Persons with only injection drug indications for PrEP without sexual risk indications outlined in inclusion criteria
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Children's Hospital Colorado
Aurora, Colorado, United States, 80045
Actively Recruiting
Research Team
A
Alex Limas
CONTACT
L
Lisa Abuogi
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
PREVENTION
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here